Scarica l'app Stockscreener
0.5455
5.10%
-0.0293
Pre-mercato:
.56
0.0145
+2.66%
Moleculin Biotech Inc Borsa (MBRX) Ultime notizie
Risk vs reward if holding onto Moleculin Biotech Inc.July 2025 Drop Watch & Fast Moving Trade Plans - Newser
Will Moleculin Biotech Inc. stock recover after recent dropEarnings Performance Report & Weekly High Return Stock Opportunities - Newser
Will Moleculin Biotech Inc. bounce back from current supportEarnings Overview Summary & Risk Managed Trade Strategies - Newser
How to manage a losing position in Moleculin Biotech Inc.July 2025 Big Picture & Reliable Entry Point Trade Alerts - Newser
Using R and stats models for Moleculin Biotech Inc. forecastingPortfolio Return Summary & Expert Approved Momentum Trade Ideas - Newser
Has Moleculin Biotech Inc. found a price floor2025 Technical Patterns & Expert Approved Momentum Ideas - Newser
Trend analysis for Moleculin Biotech Inc. this weekMarket Risk Report & Verified Short-Term Plans - Newser
Is Moleculin Biotech Inc. stock bottoming outWeekly Gains Summary & Breakout Confirmation Trade Signals - Newser
Volume spikes in Moleculin Biotech Inc. stock – what they meanJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser
Does Moleculin Biotech Inc. fit your quant trading modelJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Can Moleculin Biotech Inc. recover in the next quarterPortfolio Risk Summary & Long-Term Growth Plans - Newser
Is Moleculin Biotech Inc. stock reversal real or fakeJuly 2025 PostEarnings & Community Verified Trade Signals - Newser
Quant Funds Rotate Into Moleculin Biotech Inc. StockQuarterly Market Summary & Verified High Yield Trade Plans - beatles.ru
What’s the outlook for Moleculin Biotech Inc.’s sectorPortfolio Performance Report & Risk Controlled Stock Pick Alerts - theviewers.co.kr
Is Moleculin Biotech Inc. forming a breakout patternTake Profit & Fast Momentum Stock Entry Tips - theviewers.co.kr
Gains Recap: Is Moleculin Biotech Inc. stock undervalued right nowTrend Reversal & Trade Opportunity Analysis Reports - theviewers.co.kr
Is Moleculin Biotech Inc. stock a hidden gemJuly 2025 Weekly Recap & Advanced Swing Trade Entry Alerts - 더경남뉴스
Trend Reversal Possible in Moleculin Biotech Inc. Charts Indicate2025 Dividend Review & Free Safe Entry Trade Signal Reports - kangso.co.kr
Traders Consider Averaging Down in Moleculin Biotech Inc.Weekly Stock Report & AI Forecasted Entry and Exit Points - beatles.ru
Using Bollinger Bands to evaluate Moleculin Biotech Inc.Market Growth Report & Safe Capital Growth Tips - Newser
Combining price and volume data for Moleculin Biotech Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
What’s the recovery path for long term holders of Moleculin Biotech Inc.Weekly Gains Report & Community Verified Trade Alerts - Newser
Moleculin Biotech Releases New Corporate Presentation - TipRanks
Statistical indicators supporting Moleculin Biotech Inc.’s strengthJuly 2025 Trends & Growth Oriented Trade Recommendations - Newser
Custom watchlist performance reports with Moleculin Biotech Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - Newser
Using RSI to spot recovery in Moleculin Biotech Inc.July 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Has Moleculin Biotech Inc. Stock Ever Crashed Historical Volatility ReviewShare Buyback & Consistent Income Trade Recommendations - Newser
HC Wainwright Has Positive Estimate for MBRX Q3 Earnings - Defense World
How to use Fibonacci retracement on Moleculin Biotech Inc.Market Risk Summary & Safe Entry Trade Signal Reports - Newser
Using AI based signals to follow Moleculin Biotech Inc.2025 Top Decliners & Long-Term Safe Investment Plans - Newser
What earnings revisions data tells us about Moleculin Biotech Inc.July 2025 Rallies & Safe Capital Allocation Plans - Newser
Applying Elliott Wave Theory to Moleculin Biotech Inc.2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser
Is Moleculin Biotech Inc. stock a buy or sellJuly 2025 Selloffs & Short-Term Trading Opportunity Alerts - thegnnews.com
Webull Corporation shares rise 1.49% premarket after AIM ImmunoTech and Moleculin Biotech to present at Webull Financial Corporate Connect Webinar Series. - AInvest
Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year - MSN
Moleculin receives notice of intent to grant new European patent for Annamycin - MSN
Moleculin Biotech Misses Fiscal Q2 EPS - AOL.com
Moleculin Biotech to present at Webull Financial Corporate Connect webinar series - AInvest
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - GlobeNewswire
Late-Stage Cancer Drug Developer Moleculin Showcases Pipeline at Webull Healthcare Event - Stock Titan
Moleculin Biotech Reports Q2 2025 Financial Results - MSN
Moleculin Reports Second Quarter 2025 Financial Results and Highlights - GlobeNewswire
Moleculin Biotech Inc's Q2 2025 EPS Falls Short of Analyst Estimates, Annamycin Program Advances Amid Financial Challenges - AInvest
Moleculin Biotech: A High-Risk, High-Reward Play in Oncology Innovation Amid Capital Constraints - AInvest
Moleculin's Cancer Drug Trial Grows Globally as Critical Data Readout Approaches in 2025 - Stock Titan
Promising Developments in Annamycin Drive Buy Rating for Moleculin Biotech - TipRanks
How liquid is Moleculin Biotech Inc. stockJuly 2025 Final Week & Verified Chart Pattern Signals - newsyoung.net
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):